World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
38253
World Ranking
17357
National Ranking
8696

Overview

Paul F. Schellhammer is affiliated with Eastern Virginia Medical School in the United States, contributing primarily to the field of Medicine with a focus on several specialized subfields. Their research spans Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Genetics, and Immunology.

The main topics addressed in their work include:

  • Prostate Cancer Treatment and Research
  • Radiopharmaceutical Chemistry and Applications
  • Chronic Lymphocytic Leukemia Research
  • CAR-T cell therapy research
  • Biosimilars and Bioanalytical Methods
  • Peptidase Inhibition and Analysis
  • Cancer Immunotherapy and Biomarkers

Paul F. Schellhammer has published studies in several research venues, including:

  • Urologic Oncology Seminars and Original Investigations
  • Prostate Cancer and Prostatic Diseases
  • Clinical Genitourinary Cancer
  • Cancer Epidemiology Biomarkers & Prevention
  • UNC Libraries

Some of their recent papers are:

  • Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry (2020), published in Prostate Cancer and Prostatic Diseases
  • Open Label Phase II Study of Enzalutamide With Concurrent Administration of Radium 223 Dichloride in Patients With Castration-Resistant Prostate Cancer (2020), published in Clinical Genitourinary Cancer
  • Abstract D084: Overall survival (OS) of African-American (AA) and Caucasian (CAU) men who received sipuleucel-T for metastatic castration-resistant prostate cancer (mCRPC)-final PROCEED analysis (2020), published in Cancer Epidemiology Biomarkers & Prevention
  • A history of the Society of Urologic Oncology (2021), published in Urologic Oncology Seminars and Original Investigations
  • Use of 5-α-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline (2020), published in UNC Libraries

Frequent co-authors collaborating with Paul F. Schellhammer include:

  • Neal D. Shore
  • Ronald Tutrone
  • Richard J. Wassersug
  • Oliver Sartor
  • Andrew J. Armstrong

The breadth of research and collaboration demonstrates involvement in clinical and translational studies related to prostate cancer and immunotherapy, combining expertise in oncology and radiopharmaceutical applications with a multidisciplinary approach to cancer treatment and biomarker development.

Best Publications

  • Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

    Philip W. Kantoff;Celestia S. Higano;Neal D. Shore;E. Roy Berger

  • Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference

    Mack Roach;Gerald Hanks;Howard Thames;Paul Schellhammer

  • Placebo-Controlled Phase III Trial of Immunologic Therapy with Sipuleucel-T (APC8015) in Patients with Metastatic, Asymptomatic Hormone Refractory Prostate Cancer

    Eric J. Small;Paul F. Schellhammer;Celestia S. Higano;Charles H. Redfern

  • Consensus statement: Guidelines for PSA following radiation therapy

    James D. Cox;David J. Grignon;Richard S. Kaplan;James T. Parsons

  • Serum Protein Fingerprinting Coupled with a Pattern-matching Algorithm Distinguishes Prostate Cancer from Benign Prostate Hyperplasia and Healthy Men

    Bao Ling Adam;Yinsheng Qu;John W. Davis;Michael D. Ward

  • Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with Sipuleucel-T in advanced prostate cancer

    Celestia S. Higano;Paul F. Schellhammer;Eric J. Small;Patrick A. Burch

  • Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update

    M. Craig Hall;Sam S. Chang;Guido Dalbagni;Raj Som Pruthi

  • Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

    George L. Wright;George L. Wright;B. Mayer Grob;B. Mayer Grob;Cara Haley;Cara Haley;Katie Grossman;Katie Grossman

  • Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

    George L. Wright;Cara Haley;Mary Lou Beckett;Paul F. Schellhammer

  • Intermittent versus continuous androgen deprivation in prostate cancer.

    Maha Hussain;Catherine M. Tangen;Donna L. Berry;Celestia S. Higano

  • Development of a Novel Proteomic Approach for the Detection of Transitional Cell Carcinoma of the Bladder in Urine

    Antonia Vlahou;Paul F. Schellhammer;Savvas Mendrinos;Keyur Patel

  • Boosted Decision Tree Analysis of Surface-enhanced Laser Desorption/Ionization Mass Spectral Serum Profiles Discriminates Prostate Cancer from Noncancer Patients

    Yinsheng Qu;Bao Ling Adam;Yutaka Yasui;Michael D. Ward

  • Intermittent Androgen Suppression for Rising PSA Level after Radiotherapy

    J. M Crook;C. J O'Callaghan;G Duncan;D. P Dearnaley

  • Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry : a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures

    GL Wright;LH Cazares;SM Leung;S Nasim

  • Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study

    Stephen H. Culp;Paul F. Schellhammer;Michael B. Williams

  • Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel.

    J D Cox;M J Gallagher;E H Hammond;R S Kaplan

  • Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer.

    Michael F. Sarosdy;Paul Schellhammer;Gary Bokinsky;Paul Kahn

  • SERUM PROSTATE SPECIFIC ANTIGEN IS A STRONG PREDICTOR OF FUTURE PROSTATE GROWTH IN MEN WITH BENIGN PROSTATIC HYPERPLASIA

    Claus G. Roehrborn;John McCONNELL;Jaime Bonilla;Sidney Rosenblatt

  • Lower baseline prostate-specific antigen is associated with a greater overall survival benefit from sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) trial.

    Paul F. Schellhammer;Gerald Chodak;James B. Whitmore;Robert Sims

  • Intermittent Androgen Suppression for Rising PSA Level After Radiotherapy

    Juanita M. Crook;Christopher J. O’Callaghan;Graeme Duncan;David P. Dearnaley

Frequent Co-Authors

Celestia S. Higano
Celestia S. Higano University of Washington
Deborah A. Kuban
Deborah A. Kuban The University of Texas MD Anderson Cancer Center
Nicholas J. Vogelzang
Nicholas J. Vogelzang University of Nevada Reno
Mark S. Soloway
Mark S. Soloway Memorial Hospital of South Bend
Eric J. Small
Eric J. Small University of California, San Francisco
David G. McLeod
David G. McLeod Uniformed Services University of the Health Sciences
Joseph A. Smith
Joseph A. Smith Vanderbilt University Medical Center
E. David Crawford
E. David Crawford University of California, San Diego
Philip W. Kantoff
Philip W. Kantoff Memorial Sloan Kettering Cancer Center
David F. Penson
David F. Penson Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine opens up many related online degree pathways, each offering unique opportunities and advantages. For those interested in advanced practice, online dnp programs without dissertation present a flexible route to the highest level of nursing expertise, while eliminating the need for an extensive research project.

Those looking to enter the workforce quickly may benefit from online lpn programs, which provide a fast and convenient way to become a Licensed Practical Nurse. If you are passionate about mental health, fast track mental health nursing programs put you on a specialized path to address critical psychological and emotional needs.

Beyond direct patient care, the healthcare sector also needs leaders. Pursuing a health administration degree can prepare you for vital roles in hospital management, policy making, or healthcare IT. These flexible online options make it easier than ever to explore diverse roles within medicine.

Best Scientists Citing Paul F. Schellhammer

Trending Scientists

Recently Published Articles